A Curious Case of Vanishing Hepatocellular Carcinoma (HCC)

被引：0

作者：

Kwei-Nsoro, Robert ^{[1
]}

Attar, Bashar ^{[2
,3
]}

Ojemolon, Pius E. ^{[1
]}

Annor, Eugene N. ^{[4
]}

Go, Benjamin ^{[5
]}

机构：

[1] John H Stroger Jr Hosp Cook Cty, Internal Med, Chicago, IL 60612 USA

[2] Rush Univ, Med Ctr, Gastroenterol & Hepatol, Chicago, IL USA

[3] John H Stroger Jr Hosp Cook Cty, Gastroenterol & Hepatol, Chicago, IL USA

[4] Univ Illinois, Internal Med, Chicago, IL USA

[5] John H Stroger Jr Hosp Cook Cty, Gastroenterol, Chicago, IL USA

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 10期

关键词：

systemic inflammatory response; tumor hypoxia; alcohol related cirrhosis; spontaneous tumor regression; hepatocellular carcinoma (hcc); SPONTANEOUS REGRESSION; SPONTANEOUS NECROSIS;

D O I：

10.7759/cureus.46576

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality worldwide. Spontaneous regression of HCC is rare with few documented cases in literature. The mechanism of this phenomenon is unknown, but tumor hypoxia and systemic inflammatory response have been suggested as possible etiologies. This article aims to shed more light on this rare phenomenon and provides an opportunity to review the proposed pathophysiology of spontaneous HCC regression. In this case report, we describe an interesting case of a 39-year-old male with HCC who underwent spontaneous regression.

引用

页数：7

共 50 条

[21] Surgical management of hepatocellular carcinoma (HCC)
Philosophe, B
Langer, B
Hemming, A
Greig, P
Cattral, M
Wanless, I
Rasul, I
Baxter, N
Taylor, B
GASTROENTEROLOGY, 1997, 112 (04) : A1465 - A1465
[22] Hospice Utilization and Hepatocellular Carcinoma(HCC)
Mohess, D.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S251 - S251
[23] Biomarkers for Hepatocellular Carcinoma (HCC): An Update
Li, Dave
Satomura, Shinji
ADVANCES IN CANCER BIOMARKERS: FROM BIOCHEMISTRY TO CLINIC FOR A CRITICAL REVISION, 2015, 867 : 179 - 193
[24] Liver Transplantation for Hepatocellular Carcinoma (HCC)
Farajov, R.
Yilmaz, C.
Iakobadze, Z.
Karaca, C.
Kilic, K.
Aksu, G.
Tosun, A.
Akan, M.
Caglayan, Doganay L.
Kilic, M.
TRANSPLANTATION, 2017, 101 (05) : 308 - 308
[25] Perspectives of immunotherapy in hepatocellular carcinoma (HCC)
Buettner, N.
Schmidt, N.
Thimme, R.
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (12): : 1334 - 1342
[26] HEPADNAVIRUSES AND HEPATOCELLULAR-CARCINOMA (HCC)
ROBINSON, WS
CANCER DETECTION AND PREVENTION, 1989, 14 (02): : 245 - 252
[27] Gene signatures in hepatocellular carcinoma (HCC)
Andrisani, Ourania M.
Studach, Leo
Merle, Philippe
SEMINARS IN CANCER BIOLOGY, 2011, 21 (01) : 4 - 9
[28] Hepatocellular Carcinoma (HCC) A Global Perspective
Ferenci, Peter
Fried, Michael
Labrecque, Douglas
Bruix, Jordi
Sherman, Morris
Omata, Masao
Heathcote, Jenny
Piratsivuth, Teehra
Kew, Mike
Otegbayo, Jesse A.
Zheng, S. S.
Sarin, S.
Hamid, Saeed S.
Modawi, Salma Barakat
Fleig, Wolfgang
Fedail, Suliman
Thomson, Alan
Khan, Aamir
Malfertheiner, Peter
Lau, George
Carillo, Flair J.
Krabshuis, Justus
Le Mair, Anton
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (04) : 239 - 245
[29] Emerging Therapies for Hepatocellular Carcinoma (HCC)
Chakraborty, Eesha
Sarkar, Devanand
CANCERS, 2022, 14 (11)
[30] Epidemiology of hepatocellular carcinoma (HCC) in hemophilia
Shetty, Shrimati
Sharma, Nitika
Ghosh, Kanjaksha
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 99 : 129 - 133

← 1 2 3 4 5 →